Presentation on theme: "Blood transfusion 1. Bloodtransfusion in the Netherlands and in the LUMC 2. Haemovigilance 3. Quality indicators 4. Blood transfusion research in Leiden."— Presentation transcript:
Blood transfusion 1. Bloodtransfusion in the Netherlands and in the LUMC 2. Haemovigilance 3. Quality indicators 4. Blood transfusion research in Leiden
Blood in the Netherlands donors SanquinProducts/com ponents distribution via 4 blood establishments components Hospital bloodbanks Central facilityproductsapotheek donations
Haemovigilance in the hospital • to transfuse or not to transfuse? • and if so: the right product to the right patient.
Why Haemovigilance? • to improve the quality of - bloodproducts - transfusion medicine • to inform and educate the society
Transfusion safety > component safety
Dutch blood components are very safe The risk of transfusion-transmitted infection is nearer to that of being struck by lightening than by being struck by a motor vehicle. HBV2 : HCV2 : HIV1 :
Hepatitis C virus RNA test • introduced in UK in 1999 to detect infection missed by routine hepatitis C virus screening • had detected one additional positive sample per 1.4 million donations tested, at a cost of £ 8.3 million per detection • a suggested cost of £ 7.9 million per quality of life year gained is therefore almost certainly an underestimate (McLelland and Contreras '05)